Barings’s Calumet Specialty Products CLMT Stock Holding History

Barings’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-40,600	Closed	-$808K	–	944
2015 Q4	$808K	Buy	40,600 +3,800	+10%	+$93.9K	0.02%	537
2015 Q3	$894K	Buy	+36,800	New	+$956K	0.02%	487
2014 Q1	–	Sell	-10,465	Closed	-$272K	–	926
2013 Q4	$272K	Sell	10,465 -11,400	-52%	-$319K	0.01%	776
2013 Q3	$597K	Buy	21,865 +14,500	+197%	+$455K	0.03%	561
2013 Q2	$268K	Buy	+7,365	New	+$265K	0.01%	765

Other funds holding CLMT

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SOAMC

Spirit of America Management Corp Syosset, New York $530M AUM 36.47% 1-Year Est. Return

Barings's CLMT Position: Q1 2016 in Review

Barings sold out of Calumet Specialty Products (CLMT) in Q1 2016, closing a stake of 40,600 shares — an estimated $808K sold.

Barings first reported a position in CLMT in Q2 2013 and held it in 5 quarters. The position peaked at $894K in Q3 2015. 111 funds tracked by Wall St. Rank hold CLMT as of Q1 2016.

Barings reported no remaining Calumet Specialty Products position as of Q1 2016 after selling out during the quarter.
Barings sold 40,600 Calumet Specialty Products shares in Q1 2016, an estimated $808K.
Barings first reported a position in Calumet Specialty Products in Q2 2013 and held it in 5 quarters.
Barings's Calumet Specialty Products position peaked at $894K in Q3 2015.
111 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2016.

Based on Barings's 13F filing for Q1 2016, filed 16 May 2016.